Skip to main content
2025 CRT Conference Main banner

CRT 2025

Heart Failure

Heart Failure Summit Saturday Session Two

Panel Discussion

Saturday, March 8, 2025
5:00 PM - 5:20 PM ET

    Moderator(s)

  • Rachel Barish, NP

    Program Director, Infiltrative Cardiomyopathy
    MedStar Health

    Disclosure(s): AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 28, 2024); Johnson and Johnson: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Merck & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)

  • Ahmed Khan, MD, MS

    Advanced Heart Failure Cardiologist
    MedStar Health

    Disclosure(s): No financial relationships to disclose

  • David Xu, MD

    Advanced Heart Failure Cardiologist
    MedStar Health

    Disclosure(s): No financial relationships to disclose

    • Panel Discussant(s)

  • NA

    Nana Afari-Armah, MD

    MedStar Health

    Disclosure(s): No financial relationships to disclose

  • Patrick T. Bering, MD

    Cardiologist, Medical Director of Hypertrophic Cardiomyopathy
    MedStar Washington Hospital Center
    GLENELG, Maryland, United States

    Disclosure(s): Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Nisha Gilotra, MD

    Associate Professor of Medicine
    Johns Hopkins University School of Medicine

    No relationships to disclose

  • Jan Griffin, MD

    Associate Professor of Medicine
    Medical University of South Carolina
    Charleston, South Carolina, United States

    Disclosure information not submitted.

  • SJ

    Sandeep Jani, MD, MPH

    Medical Director, Hypertrophic Cardiomyopathy Program Baltimore, Medical director Advanced Heart Failure, Baltimore
    MedStar Health
    Baltimore, Maryland, United States

    Disclosure(s): Bristol Meyers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • AK

    Ajay Kadakkal, MD

    Attending Physician
    MedStar Health

    Disclosure(s): No financial relationships to disclose

  • Mrinalini Krishnan, MD

    Regional Director, Pulmonary Hypertension
    MedStar Health

    Disclosure(s): Janssen Pharmaceuticals: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Liquidia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); United Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)

  • Mat Maurer, MD

    Professor
    Columbia University

    Disclosure(s): Alexion: Consultant (Ongoing), Grant/Research Support (Ongoing); Alnylam: Consultant (Ongoing), Grant/Research Support (Ongoing); Astra Zeneca: Consultant (Ongoing); Attralus: Grant/Research Support (Ongoing); bridgebio: Consultant (Ongoing), Grant/Research Support (Ongoing); Ionis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer,: Grant/Research Support (Ongoing)

  • Mitchell Psotka, MD PhD

    System Chief, Heart Failure and Transplant
    Inova Schar Heart and Vascular
    Falls Church, Virginia, United States

    No relationships to disclose

  • Anirudh Rao, MD

    Palliative Medicine Physician
    MedStar Health, District of Columbia, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Rachel Barish, NP: AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 28, 2024); Johnson and Johnson: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Merck & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Ahmed Khan, MD, MS: No financial relationships to disclose
David Xu, MD: No financial relationships to disclose
Nana Afari-Armah, MD: No financial relationships to disclose
Patrick T. Bering, MD: Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Nisha Gilotra, MD: No financial relationships to disclose
Jan Griffin, MD: Astra Zeneca: Consulting Fees (e.g., advisory boards) (Ongoing); bridgebio: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Sandeep Jani, MD, MPH: Bristol Meyers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Ajay Kadakkal, MD: No financial relationships to disclose
Mrinalini Krishnan, MD: Janssen Pharmaceuticals: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Liquidia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); United Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)
Mat Maurer, MD: Alexion: Consultant (Ongoing), Grant/Research Support (Ongoing); Alnylam: Consultant (Ongoing), Grant/Research Support (Ongoing); Astra Zeneca: Consultant (Ongoing); Attralus: Grant/Research Support (Ongoing); bridgebio: Consultant (Ongoing), Grant/Research Support (Ongoing); Ionis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer,: Grant/Research Support (Ongoing)
Mitchell Psotka, MD PhD: No financial relationships to disclose
Anirudh Rao, MD: No financial relationships to disclose